Get startedLog in
    Picture of Chemomab Therapeutics logo

    CMMB — Chemomab Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Chemomab Presents Data Further Supporting The Mechanism Of Action And Potential Efficacy Of CM-101 In Primary Sclerosing Cholangitis

    Picture of Chemomab Therapeutics logoChemomab Therapeutics
    27/06/2022 13:08
    June 27 (Reuters) - Chemomab Therapeutics Ltd  CMMB.O :
    * CHEMOMAB PRESENTS DATA FURTHER SUPPORTING THE MECHANISM OF
ACTION AND POTENTIAL EFFICACY OF CM-101 IN PRIMARY SCLEROSING
CHOLANGITIS

Source text for Eikon:  ID:nPnc189kBa 
Further company coverage:  CMMB.O

    Recent news on Chemomab Therapeutics

    See all news